Market Research Reports- Consulting Analysis Crystal Market Research Continuous Glucose Monitoring Devices Market by Pr | Page 2
is growing at a higher rate in low and middle income countries. As per International Diabetes Federation,
about80% of the diabetic population resides in low and middle income countries.
Browse full research report with TOC on “Continuous Glucose Monitoring Devices Market by
Application and End User - Global Industry Analysis and Forecast to 2025” at:
http://www.crystalmarketresearch.com/report/continuous-glucose-monitoring-devices-market
Insulin pumps segment will witness a robust growth during the forecast period, while transmitters and
receivers segment occupied a major share of the CGM devices market in 2016.Sensors are disposable
components of the CGM systems which need to be replaced every 57 days. Homecare diagnostics
segment dominated the global market in 2016, due to high convenience offered byCGM devices in
homecare settings for regular monitoring of blood glucose.
North America held a major share of the overall market in 2015. This is attributed to factors such as high
predominance of diabetes, growing geriatric population, and improving reimbursement policies. U.S.
dominated the North American market owing to the presence of advanced healthcare infrastructure and
high disposable income of Americans. Asia-Pacific will bring in significant growth opportunities over the
forecast period as the awareness about patient monitoring systems is on the rise along with increased
healthcare expenditure.
Technological advancements are set to drive the competitive CGM devices market during the forecast
period. Key players are highly focused on developing innovative products to sustain the market
competition. For instance, in September 2015, Medtronic launched the MiniMed connect system enabling
smartphone connectivity for CGM. In September 2016, Abbott received FDA approval for Freestyle
Libre Pro GGM System designed to provide clear visual snapshots of patients’ glucose levels. In January
2017, Dexcom launched Dexcom CLARITY Diabetes Management Solution in EMEA. This software
simplifies CGM data reporting and management.
Request a sample copy of Continuous Glucose Monitoring Devices Market Research Report @
http://www.crystalmarketresearch.com/report-sample/HC0621
Major players in the CGM devices market are Dexcom, Inc., Johnson and Johnson, Insulet Corporation,
Medtronic, Abbott Laboratories, Echo Therapeutics, Inc., Tandem Diabetes Care, Inc., Nemaura Medical
Inc., F. Hoffmann-La Roche AG, Senseonics Holdings, Inc., and GlySens Incorporated.
Key Findings of the Research Study: